« Back
Home /
Triazavirin (Riamilovir)

Triazavirin (Riamilovir)

Item no.	DCC-DC21567-250mg
Manufacturer	DCChemicals
CASRN	928659-17-0
Amount	250 mg
Quantity options	100 mg 1 g 250 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Applications	other
Specific against	other
Purity	>98%
Smiles	O=C1C([N+](=O)[O-])=NN=C2N=C(SC)[N-]N12.[H]O[H].[H]O[H].[Na+]
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Riamilovir sodium dihydrate
Similar products	928659-17-0
Available
Manufacturer - Applications	Triazavirin is a guanine nucleotide analog antiviral originally developed in Russia that has shown efficacy against influenza A and B, including the H5N1 strain. It appears that Triazavirin has shown promise in reducing influenza disease severity and associated complications.5 Given the similarities between SARS-CoV-2 and H5N1, health officials are investigating Triazavirin as an option to combat SARS-CoV-2, the coronavirus responsible for COVID-19.
Molecular Weight	286, 2
Chemical name	7-(Methylthio)-3-nitro-[1, 2, 4]triazolo[5, 1-c][1, 2, 4]triazin-4(6H)-one sodium sodium dihydrate

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 3/5/2026

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer